Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Vaccines

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Direct Photoredox Synthesis of <i>N</i>-Linked Glycoproteins.

Journal of the American Chemical Society·2026

Same author

Visible-Light Photocatalytic and Phosphine-Mediated <i>In Situ</i> Wittig Reaction of Bicyclo[1.1.0]butanes with Aryl Aldehydes.

Organic letters·2026

Same author

Amide-Based Polyene Cyclization: Stereoselective Construction of <i>cis</i>- or <i>trans</i>-Octahydrobenzo[<i>f</i>]isoquinolines.

Organic letters·2026

Same author

Benzo-Fused Medium-Sized Heterocycles with a Chiral C-N Axis from Asymmetric Cycloaddition and Skeletal Rearrangement.

Journal of the American Chemical Society·2026

Same author

Visible-Light-Driven Synthesis of Ketonyl Cysteine Compounds by Cysteine Decysteinylation with Enol Silyl Ethers Coupling.

Organic letters·2026

Same author

Concomitant Effect of Left-Wing Disaccharide, Chain Length, and Modification of C23-Aldehyde: An Effort to Develop Simple and Effective QS-21 Derivative Vaccine Adjuvants and Exploration of the Structural-Activity Relationship.

ACS omega·2026

Search research articles

Related Experiment Video

Updated: Mar 21, 2026

Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus MRSA Infection

Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus MRSA Infection

Published on: September 1, 2023

Developing a Next-Generation Vaccine Adjuvant System through Rational Design to Alleviate AS01 Adjuvant Deficiency.

Zhikuan Luo^1,2, Shijun Zhou^1,2, Hong Wang¹

¹State Key Laboratory of Natural Product Chemistry, Department of Chemistry and School of Pharmacy, Lanzhou University, Lanzhou 730000, P. R. China.

Journal of Medicinal Chemistry

|March 19, 2026

Summary

This summary is machine-generated.

New vaccine adjuvants, BST01 and BST02, offer improved immunogenicity and safety. Developed using QS-21 derivatives, these novel systems overcome limitations of AS01, paving the way for next-generation vaccines.

More Related Videos

Author Spotlight: Development and Evaluation of a Cationic Nanoemulsion-Encapsulated Retinoic Acid System for Mucosal Vaccination

Author Spotlight: Development and Evaluation of a Cationic Nanoemulsion-Encapsulated Retinoic Acid System for Mucosal Vaccination

Published on: February 23, 2024

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on: May 6, 2015

Related Experiment Videos

Last Updated: Mar 21, 2026

Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus MRSA Infection

Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus MRSA Infection

Published on: September 1, 2023

Author Spotlight: Development and Evaluation of a Cationic Nanoemulsion-Encapsulated Retinoic Acid System for Mucosal Vaccination

Author Spotlight: Development and Evaluation of a Cationic Nanoemulsion-Encapsulated Retinoic Acid System for Mucosal Vaccination

Published on: February 23, 2024

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on: May 6, 2015

Area of Science:

Vaccinology
Immunology
Biotechnology

Background:

AS01 is a potent vaccine adjuvant but faces challenges like QS-21 scarcity, storage issues, and toxicity.
Developing effective vaccine adjuvants is critical for enhancing immune responses against various diseases.

Purpose of the Study:

To develop novel nonliposomal adjuvant systems, BST01 and BST02, using simplified QS-21 derivatives.
To create cost-effective, stable, and safer vaccine adjuvants with comparable or improved immunogenicity over AS01.

Main Methods:

Synthesis of novel adjuvant systems BST01 and BST02 utilizing QS-21 derivatives.
Co-administration of BST01 and BST02 with antigens in preclinical models.
Evaluation of antibody titers, immunogenicity, and hemolytic toxicity.

Main Results:

BST01 and BST02 induced antibody titers comparable to the AS01 adjuvant when coadministered with antigen.
The novel adjuvants demonstrated reduced hemolytic toxicity compared to existing options.
Simplified QS-21 derivatives facilitated cost-effective synthesis and relaxed storage requirements.

Conclusions:

BST01 and BST02 represent promising next-generation vaccine adjuvants.
These novel adjuvants overcome key limitations of AS01, offering enhanced efficacy, safety, and practicality.
The developed adjuvant systems show potential for broader application in vaccine development.